Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript

BIOMIMETIC THERAPEUTICS, INC. (BMTI) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/06/2013 4 Novo A/S (10% Owner) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Disposed/sold 4,720,065 shares @ $0
03/06/2013 4 Christensen Thorkil K. (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Disposed/sold 2,507 shares @ $0
03/05/2013 4 Friedlaender Gary E (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 11,977 shares @ $9.07, valued at $108.6k
Paid exercise price by delivering 5,797 shares @ $9.07, valued at $52.6k
Disposed/sold 64,957 shares @ $0
Disposed/sold 14,894 shares @ $0
Disposed/sold 11,762 shares @ $0
Disposed/sold 4,258 shares @ $0
Disposed/sold 3,377 shares @ $0
Exercised 18,736 options to buy @ $5.8, valued at $108.7k
Exercised 20,000 options to buy @ $2.63, valued at $52.6k
Disposed/sold 5,831 options to buy @ $17.09, valued at $99.7k
Disposed/sold 8,840 options to buy @ $11.64, valued at $102.9k
03/05/2013 4 FEDERICO CHARLES (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 11,977 shares @ $9.0738, valued at $108.7k
Disposed/sold 27,834 shares @ $0
Exercised 18,736 options to buy @ $5.8, valued at $108.7k
Exercised 20,000 options to buy @ $2.63, valued at $52.6k
Disposed/sold 18,096 options to buy @ $17.09, valued at $309.3k
Disposed/sold 8,840 options to buy @ $11.64, valued at $102.9k
Disposed/sold 10,653 options to buy @ $9.95, valued at $106k
Disposed/sold 8,538 options to buy @ $12.66, valued at $108.1k
03/05/2013 4 Pagano Russell P. (VP, Reg. & Clinical Affairs) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 32,305 shares @ $9.0738, valued at $293.1k
Disposed/sold 44,411 shares @ $0
Exercised 70,000 options to buy @ $2.08, valued at $145.6k
Disposed/sold 10,000 options to buy @ $14.41, valued at $144.1k
Disposed/sold 35,000 options to buy @ $13.45, valued at $470.8k
Disposed/sold 35,000 options to buy @ $8.54, valued at $298.9k
Disposed/sold 35,000 options to buy @ $11.97, valued at $419k
Disposed/sold 25,000 options to buy @ $9.7, valued at $242.5k
03/05/2013 4 MURPHY JAMES G (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Disposed/sold 56,964 shares @ $0
Exercised 18,736 options to buy @ $5.8, valued at $108.7k
Exercised 20,000 options to buy @ $2.63, valued at $52.6k
Disposed/sold 5,831 options to buy @ $17.09, valued at $99.7k
Disposed/sold 8,840 options to buy @ $11.64, valued at $102.9k
Disposed/sold 10,653 options to buy @ $9.95, valued at $106k
Disposed/sold 8,538 options to buy @ $12.66, valued at $108.1k
03/05/2013 4 WATSON DOUGLAS G (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Disposed/sold 96,021 shares @ $0
Exercised 18,736 options to buy @ $5.8, valued at $108.7k
Exercised 20,000 options to buy @ $2.63, valued at $52.6k
Disposed/sold 5,831 options to buy @ $17.09, valued at $99.7k
Disposed/sold 8,840 options to buy @ $11.64, valued at $102.9k
Disposed/sold 10,653 options to buy @ $9.95, valued at $106k
Disposed/sold 8,538 options to buy @ $12.66, valued at $108.1k
03/05/2013 4 PAPASAN LARRY W (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Disposed/sold 69,517 shares @ $0
Exercised 18,376 options to buy @ $5.8, valued at $106.6k
Exercised 20,000 options to buy @ $2.63, valued at $52.6k
Disposed/sold 5,831 options to buy @ $17.09, valued at $99.7k
Disposed/sold 8,840 options to buy @ $11.64, valued at $102.9k
Disposed/sold 10,653 options to buy @ $9.95, valued at $106k
Disposed/sold 8,538 options to buy @ $12.66, valued at $108.1k
03/05/2013 4 BULLOCK LAWRENCE E (CFO) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Disposed/sold 89,151 shares @ $0
Disposed/sold 21,000 shares @ $0
Disposed/sold 112,500 options to buy @ $2.87, valued at $322.9k
Disposed/sold 27,000 options to buy @ $12.59, valued at $339.9k
Disposed/sold 25,000 options to buy @ $14.41, valued at $360.3k
Disposed/sold 30,000 options to buy @ $8.54, valued at $256.2k
Disposed/sold 37,500 options to buy @ $11.97, valued at $448.9k
Disposed/sold 40,000 options to buy @ $13.45, valued at $538k
Disposed/sold 80,000 options to buy @ $2.08, valued at $166.4k
03/05/2013 4 Lynch Samuel Eugene (President and CEO) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 77,623 shares @ $9.0738, valued at $704.3k
Disposed/sold 1,392,923 shares @ $0
Disposed/sold 5,550 shares @ $0
Exercised 51,000 options to buy @ $3.47, valued at $177k
Exercised 170,000 options to buy @ $2.08, valued at $353.6k
Disposed/sold 45,000 options to buy @ $14.41, valued at $648.5k
Disposed/sold 205,703 options to buy @ $13.88, valued at $2.9M
Disposed/sold 85,000 options to buy @ $13.45, valued at $1.1M
Disposed/sold 80,000 options to buy @ $12.59, valued at $1M
Disposed/sold 80,000 options to buy @ $8.54, valued at $683.2k
Disposed/sold 75,000 options to buy @ $11.97, valued at $897.8k
03/05/2013 4 Ehrlich Christopher B (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Disposed/sold 1,250 shares @ $0
Disposed/sold 941,177 shares @ $0
Disposed/sold 857,692 shares @ $0
Disposed/sold 6,846 shares @ $0
Disposed/sold 24,538 shares @ $0
Disposed/sold 5,831 options to buy @ $17.09, valued at $99.7k
Disposed/sold 8,840 options to buy @ $11.64, valued at $102.9k
01/24/2013 4 Pagano Russell P. (VP, Reg. & Clinical Affairs) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Sold 1,381 shares @ $8.101, valued at $11.2k
06/12/2012 4 WATSON DOUGLAS G (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
06/12/2012 4 PAPASAN LARRY W (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
06/12/2012 4 MURPHY JAMES G (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
06/12/2012 4 Friedlaender Gary E (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
06/12/2012 4 FEDERICO CHARLES (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
04/04/2012 4 Friedlaender Gary E (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
03/30/2012 4 Lynch Samuel Eugene (President and CEO) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
03/29/2012 4 PAPASAN LARRY W (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
03/28/2012 4 Lynch Samuel Eugene (President and CEO) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
03/28/2012 4 Douglas Earl Martin (General Counsel) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
03/21/2012 4 BULLOCK LAWRENCE E (CFO) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
03/21/2012 4 Friedlaender Gary E (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
03/21/2012 4 Lynch Samuel Eugene (President and CEO) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
03/02/2012 4 Lynch Samuel Eugene (President and CEO) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
03/02/2012 4 Douglas Earl Martin (General Counsel) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
03/02/2012 4 BULLOCK LAWRENCE E (CFO) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
03/02/2012 4 Pagano Russell P. (VP, Reg. & Clinical Affairs) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
10/14/2011 4 Douglas Earl Martin (General Counsel) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
10/11/2011 4 Douglas Earl Martin (General Counsel) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
10/05/2011 4 Douglas Earl Martin (General Counsel) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
05/31/2011 4 Friedlaender Gary E (Director) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Exercised 7,500 options to buy @ $7.96, valued at $59.7k
05/20/2011 4 Pagano Russell P. (VP, Reg. & Clinical Affairs) has filed a Form 4 on BIOMIMETIC THERAPEUTICS, INC.
Txns: Bought 1,900 shares @ $7.9493, valued at $15.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy